# biote Corp.: filings

BTMD · Nasdaq · CIK 1819253 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/btmd.md) · [Financials](/companies/btmd/financials.md) · [Filings](/companies/btmd/filings.md) · [Insiders](/companies/btmd/insiders.md)

## Reports and events: 108 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 105, 8-K 63, 424B3 49, 3 23, 10-Q 17, CORRESP 14, DEFA14A 11, UPLOAD 11, 4/A 10, EFFECT 10, SC 13G/A 10, SC 13G 8, S-1/A 6, 10-K 5, POS AM 5, S-8 5, 8-K/A 4, ARS 4, DEF 14A 4, NT 10-Q 4, S-1 4, SCHEDULE 13G/A 4, 10-Q/A 3, 25-NSE 2, 424B4 2, 425 2, 8-A12B 2, CERT 2, PRER14A 2, S-4/A 2, 144 1, DEFM14A 1, DEFR14A 1, DEL AM 1, DRS 1, DRS/A 1, NT 10-K 1, PREM14A 1, S-4 1, SC 13D 1, SCHEDULE 13D 1, SCHEDULE 13G 1, SC TO-I 1, SC TO-I/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-07 | 16:30 ET | [10-Q](/filings/0001193125-26-340364.md) | Quarterly report, period 2026-06-30 | 0001193125-26-340364 |
| 2026-08-05 | 16:20 ET | [8-K](/filings/0001193125-26-335200.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-335200 |
| 2026-06-17 | 16:05 ET | [8-K/A](/filings/0001193125-26-274137.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-274137 |
| 2026-06-02 | 17:17 ET | [8-K](/filings/0001193125-26-253858.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-253858 |
| 2026-05-18 | 16:30 ET | [8-K](/filings/0001193125-26-229013.md) | 5.07 Shareholder vote results | 0001193125-26-229013 |
| 2026-05-11 | 16:11 ET | [10-Q](/filings/0001193125-26-216780.md) | Quarterly report, period 2026-03-31 | 0001193125-26-216780 |
| 2026-05-06 | 16:10 ET | [8-K](/filings/0001193125-26-208965.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-208965 |
| 2026-04-03 | 16:10 ET | [8-K](/filings/0001193125-26-142147.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-142147 |
| 2026-04-02 | 16:10 ET | [DEF 14A](/filings/0001193125-26-140096.md) | Proxy statement, period 2026-05-12 | 0001193125-26-140096 |
| 2026-03-13 | 16:04 ET | [10-K](/filings/0001193125-26-106099.md) | Annual report, period 2025-12-31 | 0001193125-26-106099 |
| 2026-03-11 | 16:08 ET | [8-K](/filings/0001193125-26-102129.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-102129 |
| 2026-01-26 | 17:21 ET | [8-K](/filings/0001193125-26-022818.md) | 8.01 Other events | 0001193125-26-022818 |
| 2025-11-07 | 16:05 ET | [10-Q](/filings/0001193125-25-272294.md) | Quarterly report, period 2025-09-30 | 0001193125-25-272294 |
| 2025-11-05 | 16:08 ET | [8-K](/filings/0001193125-25-266910.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-266910 |
| 2025-08-08 | 16:01 ET | [10-Q](/filings/0000950170-25-105800.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105800 |
| 2025-08-06 | 16:10 ET | [8-K](/filings/0000950170-25-104014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104014 |
| 2025-06-12 | 21:17 ET | [SCHEDULE 13D](/filings/0000919574-25-003576.md) | Ownership report, active investor | 0000919574-25-003576 |
| 2025-06-09 | 16:40 ET | [8-K](/filings/0001193125-25-137873.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-137873 |
| 2025-06-05 | 08:22 ET | [8-K](/filings/0001193125-25-135341.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-135341 |
| 2025-05-14 | 16:15 ET | [8-K](/filings/0001193125-25-119861.md) | 5.07 Shareholder vote results | 0001193125-25-119861 |
| 2025-05-09 | 16:21 ET | [10-Q](/filings/0000950170-25-068059.md) | Quarterly report, period 2025-03-31 | 0000950170-25-068059 |
| 2025-05-07 | 16:06 ET | [8-K](/filings/0000950170-25-065638.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0000950170-25-065638 |
| 2025-04-24 | 16:15 ET | [8-K](/filings/0001193125-25-093531.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-093531 |
| 2025-04-03 | 16:53 ET | [DEF 14A](/filings/0001193125-25-072431.md) | Proxy statement, period 2025-05-13 | 0001193125-25-072431 |
| 2025-03-17 | 08:06 ET | [8-K](/filings/0001193125-25-055224.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-055224 |
| 2025-03-14 | 16:04 ET | [10-K](/filings/0000950170-25-039394.md) | Annual report, period 2024-12-31 | 0000950170-25-039394 |
| 2025-03-12 | 16:20 ET | [8-K](/filings/0001193125-25-052946.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-052946 |
| 2025-01-30 | 16:45 ET | [8-K](/filings/0001193125-25-017314.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-017314 |
| 2024-11-12 | 17:16 ET | [10-Q](/filings/0000950170-24-125678.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125678 |
| 2024-11-12 | 16:16 ET | [8-K](/filings/0001193125-24-255973.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-255973 |
| 2024-08-09 | 13:52 ET | [10-Q](/filings/0000950170-24-094529.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094529 |
| 2024-08-08 | 16:13 ET | [8-K](/filings/0001193125-24-196974.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-196974 |
| 2024-07-05 | 16:05 ET | [8-K](/filings/0001193125-24-175600.md) | 1.01 Entry into a material agreement | 0001193125-24-175600 |
| 2024-07-03 | 16:06 ET | [8-K](/filings/0001193125-24-175041.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-175041 |
| 2024-06-21 | 20:31 ET | [8-K](/filings/0001193125-24-164885.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-164885 |
| 2024-05-24 | 07:30 ET | [8-K](/filings/0001193125-24-146528.md) | 5.07 Shareholder vote results | 0001193125-24-146528 |
| 2024-05-10 | 15:05 ET | [10-Q](/filings/0000950170-24-057713.md) | Quarterly report, period 2024-03-31 | 0000950170-24-057713 |
| 2024-05-07 | 16:18 ET | [8-K](/filings/0001193125-24-133133.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-133133 |
| 2024-04-29 | 16:24 ET | [8-K](/filings/0001193125-24-122394.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-122394 |
| 2024-04-11 | 16:16 ET | [DEF 14A](/filings/0001193125-24-093250.md) | Proxy statement, period 2024-05-21 | 0001193125-24-093250 |
| 2024-03-15 | 14:52 ET | [10-K](/filings/0000950170-24-032101.md) | Annual report, period 2023-12-31 | 0000950170-24-032101 |
| 2024-03-14 | 16:06 ET | [8-K](/filings/0001193125-24-067887.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-067887 |
| 2024-03-12 | 16:43 ET | [8-K](/filings/0001193125-24-065961.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-065961 |
| 2024-02-20 | 16:19 ET | [8-K](/filings/0001193125-24-040005.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-040005 |
| 2024-01-25 | 16:33 ET | [8-K](/filings/0001193125-24-015456.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-015456 |
| 2024-01-17 | 16:39 ET | [8-K](/filings/0001193125-24-009293.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-009293 |
| 2024-01-11 | 16:37 ET | [8-K](/filings/0001193125-24-006634.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-006634 |
| 2023-11-13 | 16:30 ET | [10-Q](/filings/0000950170-23-063027.md) | Quarterly report, period 2023-09-30 | 0000950170-23-063027 |
| 2023-11-07 | 17:10 ET | [8-K](/filings/0001193125-23-272557.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-272557 |
| 2023-08-11 | 15:09 ET | [10-Q](/filings/0000950170-23-041796.md) | Quarterly report, period 2023-06-30 | 0000950170-23-041796 |

Page 1 of 3. [Older](/companies/btmd/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.